Cleared Traditional

K872071 - CHROMOTITRE E.I.A. RUBELLA IGG

K872071 is an FDA 510(k) clearance for CHROMOTITRE E.I.A. RUBELLA IGG, manufactured by Ismunit Istituto Immunologico Intaliano. The device is a Class 2 Microbiology device with product code LFX cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K872071 · Ismunit Istituto Immunologico Intaliano · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1987
Decision
87d
Days
Class 2
Risk

K872071 is an FDA 510(k) clearance for the CHROMOTITRE E.I.A. RUBELLA IGG. Classified as Enzyme Linked Immunoabsorbent Assay, Rubella (product code LFX), Class II - Special Controls.

Submitted by Ismunit Istituto Immunologico Intaliano (Roma, IT). The FDA issued a Cleared decision on August 24, 1987 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3510 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ismunit Istituto Immunologico Intaliano devices

FDA 510(k) Submission Details - K872071

510(k) Number K872071 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 29, 1987
Decision Date August 24, 1987
Days to Decision 87 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 102d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LFX Device Classification - Class 2, Special Controls

Product Code LFX Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LFX Enzyme Linked Immunoabsorbent Assay, Rubella

All 80
Devices cleared under the same product code (LFX) and FDA review panel - the closest regulatory comparables to K872071.
THE DDI SERODOT RUBELLA IGG TEST KIT
K875368 · Disease Detection International, Inc. · Mar 1988
MODIFICATION RUBELLA IGM EIA TEST KIT
K873780 · Labsystems, Inc. · Oct 1987
VIRGO(TM) RUBELLA IGG ELISA
K873088 · Electro-Nucleonics Laboratories, Inc. · Sep 1987
RUBELLA MICROASSAY
K864602 · Diamedix Corp. · Apr 1987
RUBELLA IGM EIA TEST KIT
K862431 · Labsystems, Inc. · Aug 1986
RUBELLA ELISA TEST SYSTEM CATALOG NUMBER: 4540
K860145 · Clinical Sciences, Inc. · Jul 1986